Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the 2014 Leerink Global Healthcare Conference.
Help employers find you! Check out all the jobs and post your resume.
